APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyclic Peptide Compounds

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cyclic Peptide Compounds Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025187 pages

Choose your research edition.

Industry ResearchCyclic Peptide Compounds Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclic Peptide Compounds Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Cyclic Peptide Compounds Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclic Peptide Compounds Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclic Peptide Compounds Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Cyclic Peptide Compounds market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cyclic Peptide Compounds is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cyclic Peptide Compounds is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyclic Peptide Compounds is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cyclic Peptide Compounds is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cyclic Peptide Compounds include Apellis Pharmaceuticals, Bachem, Bicycle Therapeutics, Merck, Roche (Chugai Pharmabody Research), Pfizer, Novartis and Biopharma PEG Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Cyclic Peptide Compounds output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Cyclic Peptide Compounds by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Cyclic Peptide Compounds market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cyclic Peptide Compounds and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cyclic Peptide Compounds sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cyclic Peptide Compounds market size, projected growth trends, production technologies, key applications, and end-use industries.

Cyclic Peptide Compounds Segment by Company

Apellis Pharmaceuticals

Bachem

Bicycle Therapeutics

Merck

Roche (Chugai Pharmabody Research)

Pfizer

Novartis

Biopharma PEG Scientific

Cyclic Peptide Compounds Segment by Type

Synthetic Cyclic Peptide

Natural Cyclic Peptide

Cyclic Peptide Compounds Segment by Application

Biopharmaceutical

Scientific Research

Environmental Protection

Others

Cyclic Peptide Compounds Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclic Peptide Compounds market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclic Peptide Compounds and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclic Peptide Compounds.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cyclic Peptide Compounds market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cyclic Peptide Compounds industry.

Chapter 3: Detailed analysis of Cyclic Peptide Compounds market competition landscape. Including Cyclic Peptide Compounds manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Cyclic Peptide Compounds by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Cyclic Peptide Compounds in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Cyclic Peptide Compounds Industry Trends Table 2. Cyclic Peptide Compounds Industry Drivers Table 3. Cyclic Peptide Compounds Industry Opportunities and Challenges Table 4. Cyclic Peptide Compounds Industry Restraints Table 5. Global Cyclic Peptide Compounds Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cyclic Peptide Compounds Production Value Share by Manufacturers (2021-2026) Table 7. Global Cyclic Peptide Compounds Production by Manufacturers (Tons) & (2021-2026) Table 8. Global Cyclic Peptide Compounds Production Market Share by Manufacturers Table 9. Global Cyclic Peptide Compounds Average Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Cyclic Peptide Compounds Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cyclic Peptide Compounds Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cyclic Peptide Compounds Manufacturers, Product Type & Application Table 13. Global Cyclic Peptide Compounds Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cyclic Peptide Compounds by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Synthetic Cyclic Peptide Table 17. Major Manufacturers of Natural Cyclic Peptide Table 18. Global Cyclic Peptide Compounds Production by Type 2021 VS 2025 VS 2032 (Tons) Table 19. Global Cyclic Peptide Compounds Production by Type (2021-2026) & (Tons) Table 20. Global Cyclic Peptide Compounds Production by Type (2027-2032) & (Tons) Table 21. Global Cyclic Peptide Compounds Production Market Share by Type (2021-2026) Table 22. Global Cyclic Peptide Compounds Production Market Share by Type (2027-2032) Table 23. Global Cyclic Peptide Compounds Production Value by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Cyclic Peptide Compounds Production Value by Type (2021-2026) & (Tons) Table 25. Global Cyclic Peptide Compounds Production Value by Type (2027-2032) & (Tons) Table 26. Global Cyclic Peptide Compounds Production Value Market Share by Type (2021-2026) Table 27. Global Cyclic Peptide Compounds Production Value Market Share by Type (2027-2032) Table 28. Major Manufacturers of Biopharmaceutical Table 29. Major Manufacturers of Scientific Research Table 30. Major Manufacturers of Environmental Protection Table 31. Major Manufacturers of Others Table 32. Global Cyclic Peptide Compounds Production by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Cyclic Peptide Compounds Production by Application (2021-2026) & (Tons) Table 34. Global Cyclic Peptide Compounds Production by Application (2027-2032) & (Tons) Table 35. Global Cyclic Peptide Compounds Production Market Share by Application (2021-2026) Table 36. Global Cyclic Peptide Compounds Production Market Share by Application (2027-2032) Table 37. Global Cyclic Peptide Compounds Production Value by Application 2021 VS 2025 VS 2032 (Tons) Table 38. Global Cyclic Peptide Compounds Production Value by Application (2021-2026) & (Tons) Table 39. Global Cyclic Peptide Compounds Production Value by Application (2027-2032) & (Tons) Table 40. Global Cyclic Peptide Compounds Production Value Market Share by Application (2021-2026) Table 41. Global Cyclic Peptide Compounds Production Value Market Share by Application (2027-2032) Table 42. Apellis Pharmaceuticals Company Information Table 43. Apellis Pharmaceuticals Business Overview Table 44. Apellis Pharmaceuticals Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Apellis Pharmaceuticals Cyclic Peptide Compounds Product Portfolio Table 46. Apellis Pharmaceuticals Recent Development Table 47. Bachem Company Information Table 48. Bachem Business Overview Table 49. Bachem Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 50. Bachem Cyclic Peptide Compounds Product Portfolio Table 51. Bachem Recent Development Table 52. Bicycle Therapeutics Company Information Table 53. Bicycle Therapeutics Business Overview Table 54. Bicycle Therapeutics Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 55. Bicycle Therapeutics Cyclic Peptide Compounds Product Portfolio Table 56. Bicycle Therapeutics Recent Development Table 57. Merck Company Information Table 58. Merck Business Overview Table 59. Merck Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 60. Merck Cyclic Peptide Compounds Product Portfolio Table 61. Merck Recent Development Table 62. Roche (Chugai Pharmabody Research) Company Information Table 63. Roche (Chugai Pharmabody Research) Business Overview Table 64. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 65. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Portfolio Table 66. Roche (Chugai Pharmabody Research) Recent Development Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 70. Pfizer Cyclic Peptide Compounds Product Portfolio Table 71. Pfizer Recent Development Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. Novartis Cyclic Peptide Compounds Product Portfolio Table 76. Novartis Recent Development Table 77. Biopharma PEG Scientific Company Information Table 78. Biopharma PEG Scientific Business Overview Table 79. Biopharma PEG Scientific Cyclic Peptide Compounds Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Biopharma PEG Scientific Cyclic Peptide Compounds Product Portfolio Table 81. Biopharma PEG Scientific Recent Development Table 82. Global Cyclic Peptide Compounds Production by Region: 2021 VS 2025 VS 2032 (Tons) Table 83. Global Cyclic Peptide Compounds Production by Region (2021-2026) & (Tons) Table 84. Global Cyclic Peptide Compounds Production Market Share by Region (2021-2026) Table 85. Global Cyclic Peptide Compounds Production Forecast by Region (2027-2032) & (Tons) Table 86. Global Cyclic Peptide Compounds Production Market Share Forecast by Region (2027-2032) Table 87. Global Cyclic Peptide Compounds Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Global Cyclic Peptide Compounds Production Value by Region (2021-2026) & (US$ Million) Table 89. Global Cyclic Peptide Compounds Production Value Share by Region (2021-2026) Table 90. Global Cyclic Peptide Compounds Production Value by Region (2027-2032) & (US$ Million) Table 91. Global Cyclic Peptide Compounds Production Value Share by Region: (2027-2032) & (US$ Million) Table 92. Global Cyclic Peptide Compounds Market Average Price (US$/Kg) by Region (2021-2026) Table 93. Global Cyclic Peptide Compounds Market Average Price (US$/Kg) by Region (2027-2032) Table 94. Global Cyclic Peptide Compounds Consumption by Region: 2021 VS 2025 VS 2032 (Tons) Table 95. Global Cyclic Peptide Compounds Consumption by Region (2021-2026) & (Tons) Table 96. Global Cyclic Peptide Compounds Consumption Market Share by Region (2021-2026) Table 97. Global Cyclic Peptide Compounds Consumption Forecasted by Region (2027-2032) & (Tons) Table 98. Global Cyclic Peptide Compounds Consumption Forecasted Market Share by Region (2027-2032) Table 99. North America Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 100. North America Cyclic Peptide Compounds Consumption by Country (2021-2026) & (Tons) Table 101. North America Cyclic Peptide Compounds Consumption by Country (2027-2032) & (Tons) Table 102. Europe Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 103. Europe Cyclic Peptide Compounds Consumption by Country (2021-2026) & (Tons) Table 104. Europe Cyclic Peptide Compounds Consumption by Country (2027-2032) & (Tons) Table 105. Asia Pacific Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 106. Asia Pacific Cyclic Peptide Compounds Consumption by Country (2021-2026) & (Tons) Table 107. Asia Pacific Cyclic Peptide Compounds Consumption by Country (2027-2032) & (Tons) Table 108. South America Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 109. South America Cyclic Peptide Compounds Consumption by Country (2021-2026) & (Tons) Table 110. South America Cyclic Peptide Compounds Consumption by Country (2027-2032) & (Tons) Table 111. Middle East & Africa Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 112. Middle East & Africa Cyclic Peptide Compounds Consumption by Country (2021-2026) & (Tons) Table 113. Middle East & Africa Cyclic Peptide Compounds Consumption by Country (2027-2032) & (Tons) Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Cyclic Peptide Compounds Distributors List Table 117. Cyclic Peptide Compounds Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Cyclic Peptide Compounds Product Image Figure 2. Global Cyclic Peptide Compounds Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyclic Peptide Compounds Production Value (2021-2032) & (US$ Million) Figure 4. Global Cyclic Peptide Compounds Production Capacity (2021-2032) & (Tons) Figure 5. Global Cyclic Peptide Compounds Production (2021-2032) & (Tons) Figure 6. Global Cyclic Peptide Compounds Average Price (US$/Kg) & (2021-2032) Figure 7. Global Top 5 and 10 Cyclic Peptide Compounds Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Synthetic Cyclic Peptide Image Figure 10. Natural Cyclic Peptide Image Figure 11. Global Cyclic Peptide Compounds Production by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Cyclic Peptide Compounds Production Market Share 2021 VS 2025 VS 2032 Figure 13. Global Cyclic Peptide Compounds Production Market Share by Type (2021-2032) Figure 14. Global Cyclic Peptide Compounds Production Value by Type (2021 VS 2025 VS 2032) & (Tons) Figure 15. Global Cyclic Peptide Compounds Production Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cyclic Peptide Compounds Production Value Share by Type (2021-2032) Figure 17. Biopharmaceutical Image Figure 18. Scientific Research Image Figure 19. Environmental Protection Image Figure 20. Others Image Figure 21. Global Cyclic Peptide Compounds Production by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Cyclic Peptide Compounds Production Market Share 2021 VS 2025 VS 2032 Figure 23. Global Cyclic Peptide Compounds Production Market Share by Application (2021-2032) Figure 24. Global Cyclic Peptide Compounds Production Value by Application (2021 VS 2025 VS 2032) & (Tons) Figure 25. Global Cyclic Peptide Compounds Production Value Share 2021 VS 2025 VS 2032 Figure 26. Global Cyclic Peptide Compounds Production Value Share by Application (2021-2032) Figure 27. Global Cyclic Peptide Compounds Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Cyclic Peptide Compounds Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Cyclic Peptide Compounds Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Cyclic Peptide Compounds Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Cyclic Peptide Compounds Production Value (2021-2032) & (US$ Million) Figure 32. Europe Cyclic Peptide Compounds Production Value (2021-2032) & (US$ Million) Figure 33. Asia-Pacific Cyclic Peptide Compounds Production Value (2021-2032) & (US$ Million) Figure 34. South America Cyclic Peptide Compounds Production Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Cyclic Peptide Compounds Production Value (2021-2032) & (US$ Million) Figure 36. North America Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 37. North America Cyclic Peptide Compounds Consumption Market Share by Country (2021-2032) Figure 38. U.S. Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 39. Canada Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 40. Mexico Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 41. Europe Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 42. Europe Cyclic Peptide Compounds Consumption Market Share by Country (2021-2032) Figure 43. Germany Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 44. France Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. U.K. Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. Italy Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 47. Netherlands Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 48. Asia Pacific Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 49. Asia Pacific Cyclic Peptide Compounds Consumption Market Share by Country (2021-2032) Figure 50. China Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 51. Japan Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. South Korea Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. Southeast Asia Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 54. India Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. Australia Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 56. South America Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 57. South America Cyclic Peptide Compounds Consumption Market Share by Country (2021-2032) Figure 58. Brazil Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 59. Argentina Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 60. Chile Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 61. Colombia Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 62. Middle East & Africa Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 63. Middle East & Africa Cyclic Peptide Compounds Consumption Market Share by Country (2021-2032) Figure 64. Egypt Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 65. South Africa Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 66. Israel Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 67. Türkiye Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 68. GCC Countries Cyclic Peptide Compounds Consumption and Growth Rate (2021-2032) & (Tons) Figure 69. Cyclic Peptide Compounds Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Cyclic Peptide Compounds Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Synthetic Cyclic Peptide
  • Natural Cyclic Peptide
Applications
  • Biopharmaceutical
  • Scientific Research
  • Environmental Protection
  • Others
Companies covered
  • Apellis Pharmaceuticals
  • Bachem
  • Bicycle Therapeutics
  • Merck
  • Roche (Chugai Pharmabody Research)
  • Pfizer
  • Novartis
  • Biopharma PEG Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cyclic Peptide Compounds Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cyclic Peptide Compounds Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Cyclic Peptide Compounds Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Cyclic Peptide Compounds Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Cyclic Peptide Compounds Market Dynamics
  1. 2.1 Cyclic Peptide Compounds Industry Trends
  2. 2.2 Cyclic Peptide Compounds Industry Drivers
  3. 2.3 Cyclic Peptide Compounds Industry Opportunities and Challenges
  4. 2.4 Cyclic Peptide Compounds Industry Restraints
3 Cyclic Peptide Compounds Market by Manufacturers
  1. 3.1 Global Cyclic Peptide Compounds Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Cyclic Peptide Compounds Production by Manufacturers (2021-2026)
  3. 3.3 Global Cyclic Peptide Compounds Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Cyclic Peptide Compounds Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cyclic Peptide Compounds Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cyclic Peptide Compounds Manufacturers, Product Type & Application
  7. 3.7 Global Cyclic Peptide Compounds Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cyclic Peptide Compounds Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cyclic Peptide Compounds Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Cyclic Peptide Compounds Tier 1, Tier 2, and Tier 3
4 Cyclic Peptide Compounds Market by Type
  1. 4.1 Cyclic Peptide Compounds Type Introduction
  2. 4.1.1 Synthetic Cyclic Peptide
  3. 4.1.2 Natural Cyclic Peptide
  4. 4.2 Global Cyclic Peptide Compounds Production by Type
  5. 4.2.1 Global Cyclic Peptide Compounds Production by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cyclic Peptide Compounds Production by Type (2021-2032)
  7. 4.2.3 Global Cyclic Peptide Compounds Production Market Share by Type (2021-2032)
  8. 4.3 Global Cyclic Peptide Compounds Production Value by Type
  9. 4.3.1 Global Cyclic Peptide Compounds Production Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cyclic Peptide Compounds Production Value by Type (2021-2032)
  11. 4.3.3 Global Cyclic Peptide Compounds Production Value Market Share by Type (2021-2032)
5 Cyclic Peptide Compounds Market by Application
  1. 5.1 Cyclic Peptide Compounds Application Introduction
  2. 5.1.1 Biopharmaceutical
  3. 5.1.2 Scientific Research
  4. 5.1.3 Environmental Protection
  5. 5.1.4 Others
  6. 5.2 Global Cyclic Peptide Compounds Production by Application
  7. 5.2.1 Global Cyclic Peptide Compounds Production by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cyclic Peptide Compounds Production by Application (2021-2032)
  9. 5.2.3 Global Cyclic Peptide Compounds Production Market Share by Application (2021-2032)
  10. 5.3 Global Cyclic Peptide Compounds Production Value by Application
  11. 5.3.1 Global Cyclic Peptide Compounds Production Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Cyclic Peptide Compounds Production Value by Application (2021-2032)
  13. 5.3.3 Global Cyclic Peptide Compounds Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Apellis Pharmaceuticals
  2. 6.1.1 Apellis Pharmaceuticals Company Information
  3. 6.1.2 Apellis Pharmaceuticals Business Overview
  4. 6.1.3 Apellis Pharmaceuticals Cyclic Peptide Compounds Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Apellis Pharmaceuticals Cyclic Peptide Compounds Product Portfolio
  6. 6.1.5 Apellis Pharmaceuticals Recent Developments
  7. 6.2 Bachem
  8. 6.2.1 Bachem Company Information
  9. 6.2.2 Bachem Business Overview
  10. 6.2.3 Bachem Cyclic Peptide Compounds Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Bachem Cyclic Peptide Compounds Product Portfolio
  12. 6.2.5 Bachem Recent Developments
  13. 6.3 Bicycle Therapeutics
  14. 6.3.1 Bicycle Therapeutics Company Information
  15. 6.3.2 Bicycle Therapeutics Business Overview
  16. 6.3.3 Bicycle Therapeutics Cyclic Peptide Compounds Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Bicycle Therapeutics Cyclic Peptide Compounds Product Portfolio
  18. 6.3.5 Bicycle Therapeutics Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Cyclic Peptide Compounds Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Merck Cyclic Peptide Compounds Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Roche (Chugai Pharmabody Research)
  26. 6.5.1 Roche (Chugai Pharmabody Research) Company Information
  27. 6.5.2 Roche (Chugai Pharmabody Research) Business Overview
  28. 6.5.3 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Portfolio
  30. 6.5.5 Roche (Chugai Pharmabody Research) Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Cyclic Peptide Compounds Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Cyclic Peptide Compounds Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Novartis
  38. 6.7.1 Novartis Company Information
  39. 6.7.2 Novartis Business Overview
  40. 6.7.3 Novartis Cyclic Peptide Compounds Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Novartis Cyclic Peptide Compounds Product Portfolio
  42. 6.7.5 Novartis Recent Developments
  43. 6.8 Biopharma PEG Scientific
  44. 6.8.1 Biopharma PEG Scientific Company Information
  45. 6.8.2 Biopharma PEG Scientific Business Overview
  46. 6.8.3 Biopharma PEG Scientific Cyclic Peptide Compounds Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 Biopharma PEG Scientific Cyclic Peptide Compounds Product Portfolio
  48. 6.8.5 Biopharma PEG Scientific Recent Developments
7 Global Cyclic Peptide Compounds Production by Region
  1. 7.1 Global Cyclic Peptide Compounds Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Cyclic Peptide Compounds Production by Region (2021-2032)
  3. 7.2.1 Global Cyclic Peptide Compounds Production by Region (2021-2026)
  4. 7.2.2 Global Cyclic Peptide Compounds Production Forecast by Region (2027-2032)
  5. 7.3 Global Cyclic Peptide Compounds Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Cyclic Peptide Compounds Production Value by Region (2021-2032)
  7. 7.4.1 Global Cyclic Peptide Compounds Production Value by Region (2021-2026)
  8. 7.4.2 Global Cyclic Peptide Compounds Production Value by Region (2027-2032)
  9. 7.5 Global Cyclic Peptide Compounds Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Cyclic Peptide Compounds Production Value (2021-2032)
  12. 7.6.2 Europe Cyclic Peptide Compounds Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Cyclic Peptide Compounds Production Value (2021-2032)
  14. 7.6.4 South America Cyclic Peptide Compounds Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Cyclic Peptide Compounds Production Value (2021-2032)
8 Global Cyclic Peptide Compounds Consumption by Region
  1. 8.1 Global Cyclic Peptide Compounds Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Cyclic Peptide Compounds Consumption by Region (2021-2032)
  3. 8.2.1 Global Cyclic Peptide Compounds Consumption by Region (2021-2026)
  4. 8.2.2 Global Cyclic Peptide Compounds Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Cyclic Peptide Compounds Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Cyclic Peptide Compounds Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Cyclic Peptide Compounds Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Cyclic Peptide Compounds Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Cyclic Peptide Compounds Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Cyclic Peptide Compounds Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cyclic Peptide Compounds Value Chain Analysis
  2. 9.1.1 Cyclic Peptide Compounds Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cyclic Peptide Compounds Production Mode & Process
  6. 9.2 Cyclic Peptide Compounds Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cyclic Peptide Compounds Distributors
  9. 9.2.3 Cyclic Peptide Compounds Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst